| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/09/2008 | US7423144 Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof |
| 09/09/2008 | US7423142 double-stranded ribonucleic acid (dsRNA); degradation of the mRNA transcript of the bcl-2 gene, thereby inhibiting expression of the target gene in the cell; anticarcinogenic agent |
| 09/09/2008 | US7423133 Fluorescent glycosides and methods for their use |
| 09/09/2008 | US7423118 IAPS associated cell cycle proteins, compositions and methods of use |
| 09/09/2008 | US7423067 Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists |
| 09/09/2008 | US7423066 Dietetics; use in treatment of obesity, for reducing body weight, modulating body lipid metabolism, and reducing food intake |
| 09/09/2008 | US7423065 Preventing or treating ototoxicity by administering methioninol, hydroxyl methionine, ethionine or a salt of one of them prior to, simultaneously with, or subsequently to exposure to noise |
| 09/09/2008 | US7423063 calcium salt is calcium trifluoroacetate; to prepare medicaments with cytotoxic and antitumoral activity |
| 09/09/2008 | US7423061 Anticarcinogenic agents; tert-butyl 3-{[(2-[(aminocarbonyl)amino]-5-{4-[2-(diethylamino)ethoxy]phenyl}-3-thienyl)carbonyl]amino}piperidine-1-carboxylate |
| 09/09/2008 | US7423060 Thiophene hydroxamic acid derivatives and their use as HDAC inhibitors |
| 09/09/2008 | US7423059 Pharmaceutically active compounds and methods of use |
| 09/09/2008 | US7423058 Inhibitors of hepatitis C virus NS3 protease |
| 09/09/2008 | US7423057 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/09/2008 | US7423056 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators |
| 09/09/2008 | US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 09/09/2008 | US7423054 Therapeutic pyrazolo[3,4-b]pyridines and indazoles |
| 09/09/2008 | US7423053 e.g. 4-[4-Amino-5-(3-fluorobenzoyl)thiazol-2-ylamino]piperidine-1-carboxylic acid tert-butyl ester; inhibit cyclin-dependent kinases; antiproliferative, anticarcinogenic agent; solid tumor such as breast, lung, colon and prostate |
| 09/09/2008 | US7423052 Piperidine compounds for use as orexin receptor antagoinst |
| 09/09/2008 | US7423051 e.g. [2-Amino-6-(1-methanesulfonyl-piperidin-4-ylamino)-pyridin-3-yl]-(2-methoxy-phenyl)-methanone; inhibit cyclin-dependent kinases; cell cycle from G1 to S phase; antiproliferative, anticarcinogenic agent; solid tumors |
| 09/09/2008 | US7423050 2,4,6-trifluoro-N-[6-[(1-methyl-4-piperidinyl)carbonyl]-2-pyridinyl]-benzamide (hemisuccinate/hydrochloride salt); migraine; inhibit peptide extravasation, while avoiding significant vasoconstrictive activity; improved solubility |
| 09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 09/09/2008 | US7423048 eating disorders of disturbed fundus such as dyspepsia, early satiety, bloating, anorexia; fundic relaxation; 1-(1-((2,3-dihydro(1,4)dioxino(2,3-b)pyridin-3-yl)methyl) -4- piperidinyl)-2-imidazolidinone; improved pharmacokinetics, less vasoconstriction, side effect reduction, sustain release |
| 09/09/2008 | US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/09/2008 | US7423046 acetic acid (3RS,4aRS,10bRS)-6-(3,4-bis-cyclopropylmethoxyphenyl)-8,9-dimethoxy-(1,2,3,4,4a,10b)-hexahydrophenanthridin-3-yl ester, phosphodiesterase inhibitor; antiinflammatory, bronchodilator agent; bronchitis, allergic bronchitis, asthma, COPD, psoriasis, eczema, osteoarthritis, rheumatoid arthritis |
| 09/09/2008 | US7423045 e.g. amino(4-methoxy-7,7-dimethyl(7,12,12a,6a-tetrahydrochromano[4,3-b]quinolin-9-yl))methane-1-thione; increasing cellular ATP binding cassette transporter ABCA1 production ; reduces cholesterol deposition in coronary arteries; coronary artery diseases, dyslipidiemias and metabolic syndrome |
| 09/09/2008 | US7423044 A cyclopenta[d]pyrimidine, or 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine derivatives; treating metabolic disorders, type II diabetes, controlling glucose levels |
| 09/09/2008 | US7423043 4-Piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine compounds |
| 09/09/2008 | US7423042 Compounds |
| 09/09/2008 | US7423041 e.g. 3-[2-(4-Aminophenyl)ethyl]-8-benzyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 09/09/2008 | US7423040 Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same |
| 09/09/2008 | US7423039 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics |
| 09/09/2008 | US7423038 Compounds and compositions as protein kinase inhibitors |
| 09/09/2008 | US7423037 Morpholine derivatives as norepinephrine reuptake inhibitors |
| 09/09/2008 | US7423036 Long-acting betamimetics for the treatment of respiratory complaints |
| 09/09/2008 | US7423035 e.g. 5-hydroxy-8-{1-hydroxy-2-[1-(4-methoxy-benzyl)-cyclopropylamino]-ethyl}-4H-benzo[1,4]oxazin-3-one; mimetics of beta-adrenergic substances; beta 2-adrenoceptor modulator; antiinflammatory agent; chronic obstructive respiratory diseases; longer duration of activity |
| 09/09/2008 | US7423034 Benzothiazine and benzothiadiazine compounds |
| 09/09/2008 | US7423033 Hydroxyalkanoylaminolactams and related structures as inhibitors of aβ protein production |
| 09/09/2008 | US7423032 Method for treating severe heart failure and medicament therefor |
| 09/09/2008 | US7423031 Compounds and compositions as protein kinase inhibitors |
| 09/09/2008 | US7423030 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 09/09/2008 | US7423029 from endogenous or exogenous stem/progenitor cells and to normalize blood cell and platelet counts; e.g. [3-(3,4-dimethyl-9-oxo-9H-thioxanthen-2-yloxy)-2-hydroxypropyl]trimethylammonium chloride; antitumor and AIDS agent; low toxicity, side effect reduction |
| 09/09/2008 | US7423028 Injectable pharmaceutical compositions comprising sodium diclofenac and β-cyclodextrin |
| 09/09/2008 | US7423027 Methods of using gamma cyclodextrin to control blood glucose and insulin secretion |
| 09/09/2008 | US7423026 Methylated cyclodextrin complexes |
| 09/09/2008 | US7423025 For therapy of cardiovascular disease, ischemia related injuries; and neurodegenerative diseases |
| 09/09/2008 | US7423024 Recombinant human alpha-fetoprotein as an immunosuppressive agent |
| 09/09/2008 | US7423023 Enhancement of immune response using targeting molecules |
| 09/09/2008 | US7423022 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 09/09/2008 | US7423015 Treatment of p53-positive tumors with benzimidazole derivatives such as fenbendazole or mebendazole |
| 09/09/2008 | US7423012 Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
| 09/09/2008 | US7423008 From mutated Streptomyces argillaceous; antitumor agents; hypercalcemia; hypercalcuria |
| 09/09/2008 | US7422896 Compositions for DNA mediated gene silencing |
| 09/09/2008 | US7422886 Human Phosphoinositide I3 Kinase p110 Delta which interacts with p85, has a broad phosphinositide specificity and is sensitive to the same kinase inhibitors as PI3 Kinase p110A; selectively expressed in leucocytes; enhanced expression in most melanomas |
| 09/09/2008 | US7422846 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 09/09/2008 | US7422845 Detection of NO by using guanylyl cyclase and cGMP production as a readout system |
| 09/09/2008 | US7422764 Matrix-forming composition containing pectin |
| 09/09/2008 | US7422763 Acid controlled induced viscosity fiber system and uses thereof |
| 09/09/2008 | US7422756 Mixture of fatty acid and cholesterol |
| 09/09/2008 | US7422743 Using DCRS5 (SEQ ID NOs: 1 or 2) or p19 (SEQ ID NOs: 5 or 6) cytokine receptors agonist or antagonist to treat rheumatoid arthritis, asthma, allergies, chronic obstructive pulmonary disorder, interstitial lung disorder, inflammatory bowel disorder, inflammatory skin disorder |
| 09/09/2008 | US7422739 Anti-CD20 antibodies |
| 09/09/2008 | US7422735 Use of crosslinked cationic polymers in skin cosmetic and dermatological preparations |
| 09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
| 09/09/2008 | US7422110 Titration/compliance pack with increasing doses |
| 09/09/2008 | US7422013 Dry powder dispersing apparatus and methods for their use |
| 09/09/2008 | CA2508871C Crystalline form f of atorvastatin hemi-calcium salt |
| 09/09/2008 | CA2474904C Once-a-day oxycodone formulations |
| 09/09/2008 | CA2460865C Quinoline derivatives as neuropeptide y antagonists |
| 09/09/2008 | CA2451842C Chewable product including active ingredient |
| 09/09/2008 | CA2412047C Shortened synthesis of 3,3-diarylpropylamine derivatives |
| 09/09/2008 | CA2409069C Hydrogel composition for transdermal drug delivery |
| 09/09/2008 | CA2397960C Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith |
| 09/09/2008 | CA2366205C Biphenyl derivatives |
| 09/09/2008 | CA2359357C Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 09/09/2008 | CA2346868C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 09/09/2008 | CA2346069C Tablet and tablet production method |
| 09/09/2008 | CA2345409C Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis |
| 09/09/2008 | CA2336712C Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
| 09/09/2008 | CA2332389C Liposomal preparations for the application of antiseptic agents to the interior of the body |
| 09/09/2008 | CA2332174C Nutritional supplement based on blackcurrant seed oil |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/09/2008 | CA2307941C Method of altering nutritional components of milk produced by a lactating animal |
| 09/09/2008 | CA2303901C Use of d-methionine to reduce the toxicity of ototoxic drugs, noise, and radiation |
| 09/09/2008 | CA2287881C Vitamin d3 analogs with bis c-20 side chains |
| 09/09/2008 | CA2263445C Pharmaceutical aerosol composition |
| 09/09/2008 | CA2260971C New bis-platinum complexes with polyamine ligands as antitumor agents |
| 09/09/2008 | CA2252163C D-proline derivatives |
| 09/09/2008 | CA2211646C Substituted phenyl compounds as endothelin antagonists |
| 09/09/2008 | CA2181689C Guanylhydrazones for treating inflammatory conditions |
| 09/09/2008 | CA2171369C The use of virulence factors of pathogens to improve liposomal delivery of antibiotics and/or vaccines |
| 09/09/2008 | CA2162299C Pharmaceutical composition for oral delivery of flavonoids |
| 09/09/2008 | CA2153849C Method for improving breeding activity of boars by using feed for the breeding boars |
| 09/09/2008 | CA2124677C Immunopotentiatory agents and physiologically acceptable salts thereof |
| 09/04/2008 | WO2008106692A1 Pim kinase inhibitors and methods of their use |
| 09/04/2008 | WO2008106689A2 Breakthrough pain management |
| 09/04/2008 | WO2008106659A2 Methods of treating bipolar disorder and memory and/or cognitive impairment associated therewith |
| 09/04/2008 | WO2008106658A2 TRIGGERED RNAi |
| 09/04/2008 | WO2008106640A1 Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof |
| 09/04/2008 | WO2008106635A1 Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors |
| 09/04/2008 | WO2008106633A1 Methods of using benzodioxine compounds in treating sodium channel-mediated diseases or conditions |
| 09/04/2008 | WO2008106621A1 Taxane analogs for the treatment of brain cancer |